Coronavirus disease 19 and risk of hyperglycemia among Iraqi patients.
Ali H Ad'hiahNoor T Al-BayateeAeshah A AhmedPublished in: The Egyptian journal of medical human genetics (2021)
A cross-sectional observational study was conducted on 213 patients with COVID-19 who did not have a clinical history of diabetes at hospital admission. One week after hospitalization, they were stratified by random blood glucose levels. It was found that 25.4, 22.5 and 52.1% of COVID-19 patients were classified as normoglycemia, prediabetes and diabetes, respectively. The study indicated that diabetes may be a risk factor for COVID-19 or the disease may be associated with an increased risk of developing diabetes.
Keyphrases
- glycemic control
- coronavirus disease
- type diabetes
- blood glucose
- cardiovascular disease
- sars cov
- end stage renal disease
- emergency department
- ejection fraction
- healthcare
- chronic kidney disease
- newly diagnosed
- insulin resistance
- prognostic factors
- peritoneal dialysis
- metabolic syndrome
- adipose tissue
- skeletal muscle
- adverse drug
- drug induced